Dr. Bull is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
230
Houston, TX 77030Phone+1 713-704-3961Fax+1 713-704-5816
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1967 - 1970
- University of ChicagoInternship, Transitional Year, 1966 - 1967
- Stanford University School of MedicineClass of 1966
Certifications & Licensure
- CA State Medical License 1968 - Present
- TX State Medical License 1981 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer Start of enrollment: 1997 Nov 01
- Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer Start of enrollment: 1999 Aug 01
- Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer Start of enrollment: 2002 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsA rare presentation of carcinosarcoma of the bone in a young female; response with gemcitabine and docetaxelNicholas King, Keshav Kukreja, Albina Murzabdillaeva, Yasir D. Ali, Jason Willis
Clinical Sarcoma Research. 2019-07-02 - 19 citationsA review of immune therapy in cancer and a question: can thermal therapy increase tumor response?Joan M C Bull
International Journal of Hyperthermia. 2018-08-18 - 23 citationsPhase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.Guru Sonpavde, John McMannis, Yu Bai, Mamatha Seethammagari, Joan M C Bull
Cancer Immunology, Immunotherapy. 2017-06-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: